Biological Markers - Research News and Information

Thursday, January 08, 2009

Molecular identification and functional characterization of the vitamin C transporters expressed by Sertoli cells.

29 Nov 2008 Vitamin C is an essential micronutrient for the development of male germ cells. In the gonad, the germ cells are isolated from the systemic circulation by the blood-testis barrier, which consists of a basal layer of Sertoli cells that communicate ... Read more...

PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation.

29 Nov 2008 Loss of function mutations of Perk (eukaryotic translation initiation factor 2 alpha kinase 3) in humans and mice cause severe neonatal developmental defects, including diabetes, growth retardation and multiple skeletal dysplasias. Comprehensive ... Read more...

Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers.

13 Nov 2008 Cutaneous human papillomavirus (HPV) may be associated with the development of nonmelanoma skin cancer (NMSC), as suggested by reports of HPV DNA in NMSC tumors. HPV has also been investigated as an NMSC risk factor in epidemiologic studies, ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Biological Markers'

These are the very latest articles for this heading:

• Molecular identification and functional characterization of the vitamin C transporters expressed by Sertoli cells. 29 Nov 2008
• PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. 29 Nov 2008
• Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. 13 Nov 2008
• Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. 30 Oct 2008
• Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro. 30 Oct 2008
• Subcellular distribution of the insulin-like growth factor (IGF) binding proteins (IGFBPs) 2 and 3 in articular chondrocytes. 30 Oct 2008
• Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. 30 Oct 2008
• Therapeutic touch affects DNA synthesis and mineralization of human osteoblasts in culture. 30 Oct 2008
• Neonatal hypoxic/ischemic brain injury induces production of calretinin-expressing interneurons in the striatum. 30 Oct 2008
• Expression of kin of irregular chiasm-like 3/mKirre in proprioceptive neurons of the dorsal root ganglia and its interaction with nephrin in muscle spindles. 30 Oct 2008
• B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. 30 Oct 2008
• Confusing cases: clear cell but not renal cell lesions in kidney. 30 Oct 2008
• Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. 30 Oct 2008
• Using controlled clinical trials to learn more about acute drug-induced liver injury. 30 Oct 2008
• Biochemical markers for prediction of chemotherapy-induced cardiotoxicity: systematic review of the literature and recommendations for use. 30 Oct 2008
• Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion. 30 Oct 2008
• Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique. 30 Oct 2008
• Sepsis and those who are "weak of heart". 30 Oct 2008
• The value of procalcitonin to diagnose infection in critically ill patient: caveat emptor! 30 Oct 2008
• Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory? 30 Oct 2008

See a longer list of these articles.

Technical information about 'Biological Markers'

Definition: Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.

Registry Number: 0

Descriptor UI: D015415

Alternative terms: Biological Markers; Markers, Biological; Biomarkers; Marker, Biological; Biological Marker; Biologic Marker; Marker, Biologic; Biologic Markers; Markers, Biologic; Viral Markers; Viral Marker; Marker, Viral; Markers, Viral; Biochemical Marker; Marker, Biochemical; Markers, Biochemical; Biochemical Markers; Surrogate Endpoints; Endpoints, Surrogate; Surrogate End Points; End Points, Surrogate; Surrogate Endpoint; Endpoint, Surrogate; Surrogate End Point; End Point, Surrogate; Markers, Immunologic; Marker, Immunologic; Immunologic Marker; Immunologic Markers; Immune Marker; Marker, Immune; Immune Markers; Markers, Immune; Markers, Laboratory; Laboratory Markers; Marker, Laboratory; Laboratory Marker; Serum Markers; Markers, Serum; Serum Marker; Marker, Serum; Surrogate Markers; Markers, Surrogate; Surrogate Marker; Marker, Surrogate; Markers, Clinical; Clinical Markers; Marker, Clinical; Clinical Marker;

Related Mesh Headings: Molecular Probes;

Allowable Qualifiers: analysis; blood; cerebrospinal fluid; chemistry; metabolism; urine;

Tree Number: D23.101;

History Note: 89

Technical Notes: IM general only; coordinate NIM with specific substance (IM); note that many specific markers are available; DF: BIOL MARKERS